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Summary
Background: The human immunodeficiency virus type 1
(HIV-1) and other lentiviruses have the capacity to infect non-
dividing cells like macrophages. This requires import of the
preintegration complex (PIC) through the nuclear pore.
Although many cellular and viral determinants have been pro-
posed, the mechanism leading to nuclear import is not yet
understood.
Results: Using yeast two-hybrid and pull-down, we identified
and validated transportin-SR2 (TRN-SR2) as a bona fide
binding partner of HIV-1 integrase. We confirmed the biologi-
cal relevance of this interaction by RNAi. Depletion of TRN-
SR2 interfered with the replication of HIV-1 and HIV-2 but not
MoMLV in HeLaP4 cells. Knockdown of TRN-SR2 in primary
macrophages likewise interfered with HIV-1 replication. Using
Q-PCR, we pinpoint this block in replication to the early steps
of the viral lifecycle. A reduction in 2-LTR formation suggests
a block in PIC nuclear import upon siRNA-mediated knock-
down. Different lines of evidence clearly proved that the late
steps of viral replication are not affected. In an in vivo nu-
clear-import assay using labeled HIV-1 particles, the defect
in nuclear import after depletion of TRN-SR2 was directly visu-
alized. In comparison with control cell lines, the great majority
of siRNA-treated cells did not contain any PIC in the nucleus.
Conclusion:Our data clearly demonstrate that TRN-SR2 is the
nuclear-import factor of HIV.
*Correspondence: zeger.debyser@med.kuleuven.beIntroduction
Lentiviruses such as the human immunodeficiency virus type 1
(HIV-1) have the capacity to infect nondividing cells [1–3]. The
viral DNA, packed in the nucleoprotein preintegration complex
(PIC), is recognized by the cellular nuclear transport machinery
and traverses the nuclear envelope in an active and energy-de-
pendent manner to integrate into human chromatin. Although
nuclear import is a critical step in the lentiviral replication cycle
and the search for the import factor guiding the PIC into the nu-
cleus has been a long-standing focus of interest, the research
field remains highly controversial. In addition to different
known cellular import factors, three HIV-1 PIC-associated pro-
teins (matrix [MA], viral protein R [Vpr], and integrase [IN]) have
been put forward to play a crucial role in this process (for re-
views, see [4, 5]).
HIV-1 integrase (IN) processes and subsequently integrates
the viral reverse-transcribed DNA into the host genome. IN
was originally claimed to contain a bipartite nuclear localiza-
tion signal (NLS) in the C-terminal domain [6]. Later studies,
however, identified a nonclassical NLS sequence in the cata-
lytic core domain [7]. Classical in vitro import assays with dig-
itonin-permeabilized cells resulted in conflicting hypotheses.
Whereas some described an ATP-dependent import mecha-
nism not involving any known karyophylins [8], others
accredited the nuclear import of IN to an importin a- or impor-
tin a/b-dependent mechanism [6, 7, 9]. However, all different
theories have remained ambiguous so far and lack final confir-
mation in cellular HIV replication experiments.
Instead of studying the nuclear import of isolated viral pro-
teins, Fassati et al. used reverse-transcription complexes
(RTCs) in digitonin-permeabilized cells. The inhibition of HIV
but not MoMLV replication by siRNA-mediated knockdown
of importin 7 (Imp7) suggested a role in mediating the RTC nu-
clear import [10]. Although these results could not be con-
firmed in macrophages [11], Imp7 was identified as a cellular
binding partner of HIV-1 integrase by coimmunoprecipitation.
Even though strong siRNA-mediated knockdown of Imp7 was
achieved, only modest effects on HIV-1 replication were ob-
served, leaving space for speculation as to whether Imp7 is
indeed a physiological import factor of HIV-1 [12].
Most studies on nuclear import of HIV have been initiated by
the question of whether a specific import factor was capable of
guiding viral proteins alone or in a complex through the nuclear
membrane. In this study, however, we performed a yeast
two-hybrid screen (Y2H) in order to identify novel interaction
partners of HIV IN. Our special interest was directed toward
members of the nuclear-import factor family. We identified
transportin-SR2 (TRN-SR2, TNPO3) as a karyophilic interac-
tion partner of integrase.
TRN-SR1 and TRN-SR2 [13, 14] shuttle essential splicing fac-
tors, the serine/arginine-rich proteins (SR proteins), between the
nucleus and the cytoplasm and therefore are involved in the reg-
ulation of mRNA splicing. The recognition of the SR proteins by
TRN-SR1 and TRN-SR2 relies on the conserved RS domain and
requires phosphorylation [13–15]. Yun et al. [16] showed that
TRN-SR1 and TRN-SR2 are encoded by one gene (tnpo3) and
are expressed via alternativesplicing (Figure1A). Inmost tissues
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whereas the TRN-SR1 isoform was undetectable [16]. By yeast
two-hybrid screening, multiple non-SR proteins have been
identified as binding partners of TRN-SR2. The most prominent
binding partner was RNA-binding motif protein 4 (RBM4), a zinc-
finger protein involved in splicing regulation [17].
Here, we show the identification and validation of TRN-SR2
as the nuclear-import factor of HIV. Our data indicate that
TRN-SR2 mediates the HIV PIC nuclear import and therefore
facilitates HIV infection. Because TRN-SR2 is involved in HIV
replication in dividing and nondividing cells, we hypothesize
that nuclear import of the HIV PIC is required for productive
infection.
Results
Yeast Two-Hybrid Screen
In order to identify cellular factors interacting with HIV-1 inte-
grase, we used HIV-YU2 integrase as bait in a yeast two-hybrid
screen of a random primed CEMC7 cDNA library [18]. LEDGF/
p75, the best characterized cellular cofactor of HIV integration
to date [19–24], represented by far the highest number of iden-
tified yeast clones and validated the approach. Intriguingly,
a nuclear-import factor, transportin-SR2 (Figure 1A), which
had not yet been implicated in HIV-1 replication, was identified
with four yeast clones. Multiple IN clones were identified in the
reverse screen against a library of HIV genome DNA random
fragments, demonstrating the exclusivity of the interaction.
The selected IN interaction domain (SID) in TRN-SR2 was map-
ped to the N terminus (aa 62–334). The TRN-SR2 SID in IN was
mapped to its catalytic core domain (Figure 1B).
TRN-SR2 Is a Lentiviral-Specific Cofactor of IN
The specificity of the interaction of HIV-1 IN with TRN-SR2
was further analyzed in cellular pull-down assays. Recombi-
nant HIV-1 IN interacted with TRN-SR2 from HeLaP4 cell
lysates, whereas MoMLV IN did not interact with TRN-SR2
under these conditions, proving the specificity of the
interaction (Figure 1C). This finding was corroborated by
in vitro pull-down assays using recombinant TRN-SR2. Even
in the absence of any other potential binding partner, a distinct
direct interaction of HIV-1 integrase with TRN-SR2 was ob-
served (Figure S1 available online). In contrast to HIV-1,
MoMLV is a gammaretrovirus that can only infect dividing
cells and is therefore not dependent on passage through the
nuclear pore.
TRN-SR2 Knockdown Inhibits HIV Replication
To address the potential role of TRN-SR2 in HIV-1 replication,
we analyzed the effect of RNAi-mediated TRN-SR2 knock-
down on HIV-1 NL4.3 replication. First, we investigated the
effect of transient, siRNA- mediated knockdown of transpor-
tin-SR2 in HeLaP4 cells. Therefore, we designed two different
siRNAs targeting the 50 end of the TRN-SR2 transcript
(Figure 1A). Efficient knockdown was verified by western blot-
ting of cell extracts obtained at different time points after
transfection or by quantitative PCR. Transfection with each
siRNA clearly resulted in a pronounced reduction in TRN-SR2
levels, lasting for the duration of the HIV replication experi-
ments (6 days). As expected, transfection with a mismatch
siRNA (siTRN-SR_2MM) did not reduce transportin-SR2 levels
(Figure 2A). HeLaP4 cells transiently transfected with siRNA
targeting TRN-SR2 or the mismatched control were infected
with HIV-1 NL4.3 (Figure 2A). In parallel, cells were transfectedwith an unrelated control siRNA (siGFP) or siCD4, targeting
CD4 receptor expression in HeLaP4 cells, as a negative and
positive control, respectively. The efficiency of the siCD4-
mediated knockdown was confirmed by FACS analysis (data
not shown). Twenty-four hours after infection, a pronounced
decrease of HIV replication was observed with siTRN-SR_2.
After 72 hr of infection, siTRN-SR_2-mediated knockdown in-
hibited viral replication on average 6-fold when compared to
siMOCK (Figure 2A). A similar decrease in replication efficacy
was observed after knockdown of the CD4 receptor. The
siTRN-SR_2-mediated inhibition was independent of the mul-
tiplicity of infection (MOI), precluding an unspecific MOI effect
(Figure S2).
In order to rule out virus-strain-specific inhibition, we used
different HIV-1 strains (NL4.3 and IIIB) as well as a Raltegra-
vir-resistant NL4.3 strain with two resistance-determining mu-
tations (G140S, Q148H) in the integrase gene [25] (Figure 2B).
TRN-SR2 knockdown inhibited all viruses to the same extent.
Integrase-inhibitor-resistant viruses are thus still susceptible
to TRN-SR2 knockdown. As with HIV-1, TRN-SR2 knockdown
inhibited HIV-2 replication 6-fold (ROD, Figure 2B).
Next, the lentiviral specificity of the siTRN-SR_2 effect was
investigated. Therefore, HeLaP4 cells transfected with
siTRN-SR_2, siCD4 and siTRN-SR_2MM were transduced
with VSV-G-pseudotyped HIV-derived lentiviral vectors or
MoMLV-derived gammaretroviral vectors. As expected,
siCD4 had no effect on the VSV-G-mediated transductions.
Whereas lentiviral vector transduction was inhibited 6-fold
upon TRN-SR2 knockdown (in comparison with siTRN-
SR_2MM), gammaretroviral vector transduction was hardly af-
fected (Figure 2C). In this single-round experiment, CMV-pro-
motor-driven fLuc expression is Tat independent. This points
to a block of an early step of HIV replication.
Although siRNA-mediated knockdown provides a powerful
tool for target validation, artifacts have to be excluded. Indeed,
siRNA may induce unexpected off-target effects in mammalian
cells [26]. The use of two distinct siRNAs and the mismatch
control has already supported the validity of our data. Still,
the transient nature of siRNA-based knockdown in dividing
cells might complicate the interpretation of phenotypic effects
in infection experiments carried out over a period of several
days. Therefore, stable polyclonal and monoclonal knock-
down cell lines were generated with lentiviral-vector-encoded
small hairpin RNAs (shRNAs) (Figure 3). Knockdown efficiency
as determined by qPCR was similar to that obtained after tran-
sient knockdown (compare Figures 2A and 3A). TRN-SR2 ex-
pression levels may be strictly regulated because this protein
is involved in the nuclear import of essential mRNA splicing
factors [13–15]. This hypothesis is supported by the finding
that overexpression of TRN-SR2 in HeLaP4 cells for a pro-
longed period of time was not possible. Even under selection,
overexpression was lost during passaging of HeLaP4 cells.
Moreover we were not able to overexpress TRN-SR2 deletion
mutants fused to eGFP to sufficiently high levels to induce
transdominant inhibition of HIV replication (data not shown).
In cell lines stably expressing short hairpins targeting TRN-
SR2, HIV replication was reduced 20-fold (Figure 3A). In addi-
tion, viral breakthrough experiments in shTRN-SR_2 poly-
clonal knockdown cell lines did not yield virus up to 9 days
after infection (Figure 3B).
HeLaP4 is an established laboratory cell line for the study of
HIV-1 replication, but not a physiological host cell line for HIV.
Moreover, nuclear import seems absolutely required for lenti-
viral infection of nondividing cells. In order to ultimately prove
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1194Figure 1. Schematic Representation of TRN-SR and Analysis of Its Interaction with IN
(A) Schematic representation of the TRN-SR1 and TRN-SR2 splice variants of the tnpo3 gene. Both variants are involved in the nuclear import of serine/ar-
ginine-rich proteins (SR proteins). TRN-SR1 is a 975 aa protein consisting predominantly of the RanGTP-binding (aa 1–281) and the RS-protein-binding
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effect of RNAi-mediated knockdown of TRN-SR2 in primary
human macrophages (Figure 4). Macrophages were trans-
fected with siTRN-SR_2 and siTRN-SR_2MM. Comparison of
TRN-SR2 expression levels in knockdown macrophages with
cells transfected with the mismatched control by qPCR dem-
onstrated a 2-fold reduction. In these conditions and over a
period of 8 days, HIV-1 replication was persistently impaired
in macrophages transfected with siTRN-SR_2.
TRN-SR2 Knockdown Exclusively Inhibits Early Steps of
HIV Replication
Different lines of evidence (transient and stable TRN-SR2
knockdown in laboratory cell lines as well as transient knock-
down in macrophages) support the hypothesis that the kar-
yopherin TRN-SR2 is involved in HIV replication. Further-
more, interaction assays demonstrated the direct
interaction of HIV IN with TRN-SR2. On the other hand, trans-
portin-SR2 has been implicated in the nuclear import of the
essential splicing factor ASF/SF2 [14, 15]. Earlier studies
linked this splicing factor to the splicing of the viral pre-
mRNA into the multiple-spliced viral mRNAs regulating the
Rev, Env, Vpu, and Nef expression [27]. Overexpression of
ASF/SF2 in 293T cells altered the splicing pattern of HIV-1
mRNA during infection, resulting in oversplicing of mRNA
and therefore inhibiting virus production [28]. Moreover, in
the present study, even moderate knockdown of TRN-SR2
had a severe impact on HIV-1 replication (Figures 2A, 2B,
3A, and 4). Accordingly, we wondered whether knockdown
of TRN-SR2 exclusively affected early steps of HIV replication
or also indirectly affected later steps of the HIV-1 life cycle,
augmenting the inhibition of HIV replication.
For evaluation of the impact of siTRN-SR_2-mediated
knockdown on early steps of HIV-1 replication, HeLaP4 cells
were harvested at different time points after HIV-1 NL4.3 infec-
tion. DNA was extracted to quantify late reverse transcripts, 2-
LTR circles, and integrated proviruses via qPCR. siMOCK- and
siTNR-SR_2MM-transfected cells were used as controls
(Figure 5A). Of interest, a 3- to 4-fold reduction in 2-LTR circles
was evidenced in TRN-SR2 knockdown cells but not in the
mismatch control. This finding correlated with the strength of
knockdown as determined by qPCR and the 3- to 5-fold reduc-
tion of HIV replication (see Figure 2A). Likewise, proviral DNA
was hardly detectable after TRN-SR2 depletion. 1-LTR and
2-LTR circles are formed as dead-end by-products of viral rep-
lication [29]. Therefore, the number of 2-LTR circles is an indi-
rect measure for the nuclear import of the PIC. The clear
reduction in 2-LTR formation and subsequent block of integra-
tion pinpoint the block of HIV-1 replication between late
reverse transcription and the nuclear entry step.
Depletion of TRN-SR2 by siRNA did not affect p24 produc-
tion in HeLaP4 cells transfected with a molecular clone of
HIV-1 NL4.3 in comparison with the control cells (siMOCK or
siTRN-SR_2MM, Figure 5B). As expected, addition of the pro-
tease inhibitor Saquinavir (Roche) completely abolished p24
production. Moreover, the cellular distribution of thephysiological TRN-SR2 cargo, the RS-splicing factor ASF/
SF2, was not altered upon TRN-SR2 knockdown (Figure 5C).
This can be explained by the fact that ASF/SF2 can enter the
nucleus during cell division of HeLaP4. Therefore, the inhibi-
tion of HIV replication seen by TRN-SR2 knockdown is proba-
bly not due to an altered cellular distribution of ASF/SF2. Ulti-
mately, we evaluated the impact of TRN-SR2 knockdown on
the expression of multiple-spliced viral mRNA by quantitative
RT-PCR. Cell lines depleted of TRN-SR2 were transfected
with a molecular clone of HIV-1, NL4.3. No difference in multi-
ple-spliced 1.8 kb viral mRNA was detected between knock-
down and control cell lines (Figure 5D). Taken together, all
four lines of evidence support the hypothesis that TRN-SR2
is responsible for the nuclear import of the HIV PIC and does
not affect late steps in the viral life cycle.
TRN-SR2 Imports the PIC into the Nucleus
Nuclear import of cellular proteins is typically studied with re-
combinant import factors in digitonin-permeabilized cells. Al-
though such assays exponentially increased our knowledge
of nuclear import, they may lack physiological relevance for
studying viral import. Through the study of isolated viral pro-
teins instead of the viral PIC, NLS signals of viral proteins
may be exposed that are masked within the multiprotein com-
plex and therefore are not accessible for the cellular import
machinery. In agreement with earlier reports [7, 8, 10, 12], we
found that different import factors stimulated to some extent
the import of HIV IN to the nucleus (data not shown). However,
to solve the conflicting observations surrounding the nuclear
import of HIV [5], we have now applied a cellular nuclear-im-
port assay [30] to corroborate the role of TRN-SR2 in HIV infec-
tion. The efficient nuclear translocation of the PIC in HeLaP4
cells was evaluated with fluorescently labeled viral particles
containing IN fused to eGFP (HIV-IN-eGFP). IN-eGFP was in-
corporated in HIV particles by Vpr mediated transincorpora-
tion [31]. IN-eGFP was able to functionally complement IN
D64E encoded by a proviral construct, resulting in the ability
of HIV particles to integrate [30]. Immunostaining of the matrix
and capsid proved the identity of fluorescent viral particles
(data not shown). For verification of the functionality of the vi-
rions, the natural endogenous reverse transcription (NERT) ac-
tivity was assessed. De novo synthesis of cDNA was demon-
strated by incorporation of fluorescent deoxynucleotides in
extracellular virions. After infection, eGFP-labeled PICs were
associated with fluorescent-labeled cDNA (data not shown).
HeLaP4 cells treated with Alexa-568-labeled siRNA directed
against TRN-SR2 were infected for 6 hr with HIV-IN-eGFP. In
cells positive for Alexa-568, the number of intranuclear and cy-
toplasmic PICs was determined (Figure 6A). In two indepen-
dent experiments, the cellular distribution of the PICs was an-
alyzed for siTRN-SR_2- and siTRN-SR_2MM-transfected cells.
For each siRNA, 55 or 100 cells were analyzed by confocal mi-
croscopy. The average population of eGFP-labeled PICs in the
nucleus equaled 2.2% 6 0.1% of all PICs detected in mis-
match control cells. This number was similar to the number
of PICs observed in the nucleus of nontransfected HeLaP4domain (aa 558–953). TRN-SR2 (923 aa) is the predominant isoform and is transcribed via alternative splicing. The siRNAs used (siTRN-SR_1 and siTRN-
SR_2) are indicated below.
(B) Representation of the selected interaction domains (SID) of TRN-SR2 and IN. Whereas four cDNA clones of TRN-SR2 were selected by yeast two-hybrid
screening, multiple clones of HIV IN were identified in the reverse screen.
(C) TRN-SR2 interacts with HIV-1 but not with MoMLV IN (lanes 3 and 4). Pull-down assays were analyzed by western blotting. CE denotes cell extract; lanes
1, loading controls for HIV-IN and MoMLV-IN; lanes 2, pull-downs of CE without adding IN.
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1196Figure 2. Transient, siRNA-Mediated Knockdown of TRN-SR2 in HeLaP4 Cells Inhibits HIV Replication and Vector Transduction
(A) HIV replication in transient TRN-SR2 knockdown cells. Transfection of each of two different siRNAs targeting the TRN-SR2 mRNA resulted in moderate
reduction of the mRNA as determined by qPCR at the day of HIV-1 infection (left panel) (data are represented as mean6 standard deviation [SD]). Western-
blot analysis of the knockdown with siTRN-SR_2 showed strong reduction in protein levels lasting at least 6 days (lower left panel). HIV replication was mea-
sured by b-galactosidase reporter gene expression (right panel). Transient knockdown of TRN-SR2 resulted in a 6-fold inhibition of HIV-replication in
HeLaP4 cells (n = 10, data are represented as mean 6 SD). In parallel experiments, neither an unrelated siRNA (siGFP) nor the specific control (siTRN-
SR_2MM) suppressed HIV replication upon transfection. Transient knockdown of the CD4 receptor in these cell lines reduced the infectivity of HIV-1 to levels
similar to those observed with siTRN-SR_2.
(B) Transient knockdown of TRN-SR2 in HeLaP4 equally inhibited HIV-1 (NL4.3, IIIB, ZKNL4.3) and HIV-2 (ROD) replication as determined by b-galactosidase
activity after 24 hr (n = 6, data are represented as mean 6 SD).
(C) Inhibition of virus replication after transient knockdown of TRN-SR2 is specific for lentiviruses. HIV-1 expressing the luciferase reporter (HIV-fLuc) and an
HIV-1 based vector (CMV_HIV-fLuc) were inhibited 10-fold upon knockdown. In contrast, CMV_MLV-fLuc was not significantly inhibited. As expected, no
significant inhibition of replication was seen with the mismatched control and siCD4.cells [30] and reflects an apparent bottleneck during infection
with these eGFP-IN-labeled particles. Strikingly, the nuclear/
cytoplasmic ratio dropped 5-fold to 0.4% 6 0.05% in the
TRN-SR2 knock down cells. The non-parametric two-tailedKolmogorov-Smirnov test revealed a statistically highly signif-
icant difference (p < 0.001) between the two cell populations
(Figure 6B). This analysis clearly demonstrates a decrease in
the number of viral PICs in the nucleus upon TRN-SR2
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in PIC nuclear translocation.
Discussion
Various import factors and viral proteins have been implicated
in HIV nuclear import [4, 5]. Here we present the identification
and validation of TRN-SR2 as the nuclear-import factor of the
HIV PIC. Whereas identification of cellular partners of viral pro-
teins is based on a variety of screening technologies that all
have inherent rates of false positives and negatives (e.g., yeast
two-hybrid, coimmunopreciptation, and RNAi), validation of
biologically relevant interactions requires various lines of addi-
tional experimentation. For instance, after the first identifica-
tion of LEDGF/p75 as a binding partner of HIV-1 integrase in
Figure 3. shRNA-Mediated Knockdown of TRN-SR2
Blocks HIV Replication
(A) Polyclonal and monoclonal cell lines encoding
shTRN-SR_2 were obtained with moderate reduc-
tions of TRN-SR2 expression as determined by
qPCR (upper panel). Stable knockdown of TRN-
SR2 resulted in a 20-fold reduction of HIV-1 replica-
tion as determined by p24 measurement after 24 hr
and 72 hr (n = 6, data are represented as relative light
units [RLUs] and normalized on the infection of wild-
type HeLaP4 cells, mean6 SD is shown). Maximal in-
hibition was already achieved with the polyclonal cell
line; in selected monoclonal cell lines, inhibition of
HIV-1 replication was not significantly enhanced
(lower panel).
(B) Inhibition of HIV replication in shTRN-SR_2-ex-
pressing cell lines was observed over a prolonged
time course. Viral breakthrough experiments demon-
strated long-term inhibition (9 days) of replication
(one representative experiment shown).
2003 [19], it took several years and the ef-
forts of various research groups to validate
the role of LEDGF/p75 in HIV integration
[20–23, 32–38]. After identification of TRN-
SR2 as an interaction partner of HIV-IN in
yeast two-hybrid, we corroborated the rele-
vance of the interaction by pulling down
TRN-SR2 from cell lysates with HIV-1 IN
but not with MoMLV IN. Analysis of the
clones identified in yeast two-hybrid indi-
cates that TRN-SR2 interacts with the cata-
lytic core domain of IN close to its N termi-
nus. Currently, work is in progress to
design and express a set of deletion mu-
tants of both proteins for analysis by confo-
cal microscopy and recombinant protein
expression. These mutants will allow us to
define the interaction domain in detail. Ef-
forts are also ongoing to identify single-
point mutations in IN that inhibit the interac-
tion with TRN-SR2. Given that mutations in
IN tend to have pleiotropic effects on HIV
replication, conclusions will have to be
drawn with care [35, 39].
Here we demonstrated that two short in-
terfering RNAs as well as shRNAs inhibited
HIV replication drastically. We proved that
TRN-SR2 is a cofactor for various HIV-1
strains and an HIV-2 strain but not for MoMLV, suggesting len-
tiviral specificity and excluding unspecific off-target effects
(Figure 2). Several lines of evidence (qPCR and analysis of
the multiple-spliced HIV-mRNA, cellular localization of ASF/
SF2, and virus production) indicate that TRN-SR2 knockdown
does not affect late steps in the viral replication cycle. More-
over, quantitative analysis of viral DNA species directly pin-
pointed the block of HIV replication to the nuclear-import
step of the PIC (Figure 5). siRNA-mediated knockdown of
TRN-SR2 in dividing (HeLaP4) and nondividing (macrophages)
cells strongly affected the infectivity of HIV, indicating that the
transport through the nuclear envelop might be necessary for
productive infection of the host cell.
To determine the molecular mechanism of TRN-SR2 in de-
tail, we studied the nuclear import of the PIC in cells. The
Current Biology Vol 18 No 16
1198Figure 4. Effect of TRN-SR2 Knockdown in Primary Macrophages
Two independent experiments with cells from different donors are shown. Knockdown of TRN-SR2 by siTRN-SR_2 on the day of infection was analyzed by
qPCR. After infection of transiently transfected macrophages with HIV-1 YU2, viral replication was analyzed by p24 measurements in the supernatant. Com-
pared to mock or siTRN-SR_2MM-transfected macrophages, a 2-fold reduction in expression levels resulted in a 2- to 3-fold decrease in HIV replication.state-of-the-art technique is an in vitro transport system in
which recombinant transport factors and their potential
cargoes are added to digitonin-permeabilized cells (for a re-
view, see [40]). For HIV, these studies have only provided lim-
ited information to date. Because these import assays use re-
combinant integrase, NLS sequences that are normally hidden
in the PIC might get inadvertently exposed. Therefore, it is not
surprising that several karyopherins (importin a, importin b,
and importin 7) have been put forward as putative import fac-
tors of HIV-1 integrase [6, 9, 12]. So far, inhibition of HIV-1 rep-
lication after RNAi-mediated knockdown has only been
achieved for Imp7 [12]. Notwithstanding potent knockdown
of Imp7, only moderate inhibition of HIV replication wasachieved, and Zielske et al. could not detect a phenotype in
macrophages [11]. Here, we used a novel approach to study
HIV nuclear import with fluorescently labeled HIV in living cells
[30]. We obtained unambiguous results: Specific knockdown
of TRN-SR2 decreased PIC import by more than 5-fold,
corroborating TRN-SR2 as the cellular import factor of HIV-1.
Although we cannot exclude with absolute certainty the possi-
bility that a subpopulation of the eGFP-labeled particles might
not be functional, our data clearly demonstrate that in the con-
trol cells a fraction of the particles gets imported into the nu-
cleus. In contrast, siTRN-SR_2-mediated knockdown ex-
cludes the labeled PICs from the nucleus. Quantification of
the populations of PICs in the cytoplasm and the nucleus
Figure 5. siRNA-Mediated Knockdown of TRN-SR2 Exclusively Inhibits Early Steps of HIV Replication
(A) The block of HIV-1 replication upon knockdown of TRN-SR2 can be pinpointed to nuclear import. After transient transfection of siTRN-SR_2 and the
mismatched control, HeLaP4 cells were infected with HIV-1 NL4.3. At distinct time points after infection, DNA was extracted from cells and viral DNA species
were identified by qPCR (viral DNA copies, 2-LTR, provirus). Whereas all cells permit reverse transcription of viral RNA, siTRN-SR_2 transfection reduced
2-LTR circles 3-fold, indicating a block in nuclear import of the PIC. Only trace amounts of integrated virus were detectable in those cells.
(B) Cells were transfected with a molecular clone of HIV-1 NL4.3. Production of HIV-1 NL4.3 in siTRN-SR_2 knockdown cells was not hampered, demon-
strating that the siRNA does not cause late effects on viral replication. NL4.3 production in cells treated with 1 or 10 mg/ml of the protease inhibitor Saquinavir
was severely affected (n = 3, data are represented as mean 6 SD).
(C) siTRN-SR_2 does not alter the cellular distribution of ASF/SF2 as determined by western blotting. CE denotes cytoplasmic extract; NE denotes nuclear
extract; lanes 1, siMOCK; lanes 2, siTRN-SR_2; lanes 3, siTRN-SR_2MM.
(D) Analysis of multiple-spliced HIV mRNA after transient knockdown of TRN-SR2 and subsequent transfection with a molecular clone of HIV-1 NL4.3 (n = 3,
data are represented as mean6SD). Knockdown of neither TRN-SR2 nor CD4 changed the splicing pattern of the HIV mRNA. The multiple-spliced transcript
was exclusively detected in pNL4.3-transfected cells but not in the nontransfected control (HeLaP4).
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ing HIV-1 replication. This may help explain the strong pheno-
type seen upon knockdown of TRN-SR2 (Figures 2, 3, and 4).
It is well known that gammaretroviruses such as MoMLV
cannot productively infect nondividing cells. However, to
date it is not clear whether this is due to a defective nuclear im-
port and a concomitant requirement for disassembly of the nu-
clear membrane during mitosis or whether MoMLV integration
requires a cellular cofactor expressed during mitosis. The
Emerman group put forward the hypothesis that the amount
of capsid (CA) protein present in the viral PIC is the major de-
terminant for the lack of infection of nondividing cells [41, 42].In contrast to HIV, the MoMLV PIC contains high amounts of
CA. Our data indicate that TRN-SR2 acts as a cofactor of HIV
nuclear import in both dividing and nondividing cells and sug-
gest a lack of interaction between TRN-SR2 and MoMLV IN.
Whether p24 plays a role in TRN-SR2-mediated HIV nuclear
import awaits further experimentation.
While this manuscript was in preparation, Brass et al. pub-
lished an extensive siRNA screen to identify host factors of
HIV-1 IIIb replication [43]. Two hundred and seventy-three siR-
NAs that decreased HIV replication at least 2-fold were identi-
fied. Interestingly, the tnpo3 gene encoding for TRN-SR2 was
identified as a hit. Although this report did not pinpoint
Current Biology Vol 18 No 16
1200integrase as the viral partner of interaction, nor could it validate
TRN-SR2 as the nuclear-import factor of HIV, this independent
identification lends further support to our study.
To productively infect host cells, HIV needs to perform two
entry steps. First the virus has to attach to cellular membrane
(co)receptors in order to enter the cytoplasm. After stripping
the viral particle into the PIC, this multiprotein complex needs
Figure 6. Nuclear Translocation of PICs in
HeLaP4 TRN-SR2 Knockdown Cells
(A) Representative images of cells treated with
Alexa-568 (red)-labeled siTRN-SR_2 (left) and
siTRN-SR_2MM (right). Cells were infected with
HIV-IN-eGFP (green) and immunostained with
lamin A/C (blue). Six hours after infection, cells
were fixed and analyzed by laser-scanning con-
focal microscopy. Images are derived from con-
focal Z stacks with the maximum projection of
3-mm-thick slices centered in the middle of the
nucleus. Cell shapes are outlined in white. The
white bars at the lower right corner of the images
correspond to 1 mm. White arrows highlight the
PICs observed in the nuclei.
(B) Percentage of PICs in the nucleus versus cy-
toplasmic PICs in cells treated with siTRN-SR_2
(red bars, n = 100) and siTRN-SR_2MM (gray
bars, n = 100). Nearly half of the cells treated
with siTRN-SR_2 did not contain any PICs in the
nucleus, whereas in the mismatched control
cells, on average 2.2% of the PICs had been im-
ported into the nucleus. In the inset, the distribu-
tion of cumulative probabilities is plotted for
TRN-SR2 siRNA-treated cells (red) and mis-
matched siRNA-treated cells (gray) (p < 0.001,
Kolmogorov-Smirnov test).
to dock onto nuclear-import receptors
to cross the second physical barrier
against infection: the nuclear mem-
brane. Cell-fusion inhibitors like mara-
viroc and enfuvirtide have successfully
entered the clinic (for a review of HIV
drug development, see [44]). Because
nuclear import is still poorly understood
in comparison, it has remained a yet un-
explored target in anti-HIV therapy. The
strong replication defect provoked by si-
lencing of TRN-SR2 provides a rationale
for the identification of small-molecule
protein-protein interaction inhibitors to
obstruct loading of the PIC onto its nu-
clear-import factor. We believe that the
interaction between IN and TRN-SR2
shows great promise as a novel target
for future anti-HIV therapy.
Experimental Procedures
Recombinant-Protein Preparation
Recombinant proteins were expressed in E. coli
BL21 (DE3). We kindly thank Dr. Woan-Yuh Tarn
(Inst. of Biomedical Sciences, Taiwan) for the
pGEX-TRN-SR2 expression plasmid. After trans-
formation of the transportin expression plasmid,
the bacteria were grown to an optical density of
0.4, and protein expression was induced by addi-
tion of a final concentration of 0.5 mM isopropyl-
beta-D-thiogalactopyranoside. After incubation
at 37C for 4 hr, the bacteria were harvested and stored at220C until pro-
tein purification. For purification, the cells were resuspended in lysis buffer
(PBS [pH 7.3], 1 mM DTT, 1 mM EDTA, 0.2 mM PMSF, 1 ml Benzonase/10 ml
lysate). After complete lysis by ultrasonication, the supernatant was cleared
by centrifugation and recombinant proteins bound to Glutathion Sepharose
Resin (GE Healthcare, Belgium). After washing of the resin with 20 volumes
of lysis buffer, the GST-tagged protein was eluted with 10 3 1 ml elution
buffer, supplemented with 10 mM reduced glutathione (50 mM Tris/HCL,
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1201pH 7.3, 500 mM NaCl). The fractions were analyzed by SDS-PAGE for protein
content, pooled, and concentrated by dialysis (overnight, 4C) against
storage buffer (50 mM Tris/HCl, pH 7.3, 500 mM NaCl, 50 % [v/v] glycerol).
Recombinant His6-tagged HIV-1 integrase was purified as described previ-
ously [37]. Recombinant His6-tagged MoMLV-integrase was purified as
described previously [45].
Pull-down of TRN-SR2 from HeLaP4 Cells by Recombinant
HIV-1 and MLV IN
Total HeLaP4 cell extracts were prepared as follows. Twenty Mio HeLaP4
cells were lysed in lysis buffer (20 mM Tris/HCl, pH 7.3, 400 mM NaCl,
0.2% [v/v] Triton X-100, 10% [w/v] sucrose, Complete Protease Inhibitor
Cocktail [Roche, Germany]). The concentration of protein was determined
by BCA Protein Determination Assay Kit (Perbio, USA). Two hundred micro-
grams of total protein was incubated with 3 or 6 mg of recombinant HIV-1 or
MoMLV integrase on ice for 30 min in a final volume of 50 ml in order to allow
interaction of the recombinant proteins with cellular interaction partners to
occur. Subsequently, 50 ml of PD-buffer (50 mM Tris/HCl, pH 7.3, 200 mM
NaCl, 0.05 % Nonidet P-40) was added prior to addition of 30 ml Ni-che-
late-Sepharose (QIAGEN, Germany) equilibrated in PD buffer. Finally,
40 mM imidazole was added to prevent unspecific binding. Pull-down mix-
tures were incubated for 4 hr at 4C before proteins bound to the Ni-chelate
beads were collected by centrifugation (1000 RPM, 1 min, 4C). The beads
were washed twice with PD buffer supplemented with 80 mM imidazole.
Then, proteins bound to the beads were eluted by addition of 4 ml imidazole
(2 M) and SDS-page loading dye (160 mM Tris/HCl, pH 6.8, 2% [w/v] SDS,
200 mM DTT, 40 % glycerol, 0.1 % [w/v] bromphenol blue). Subsequently,
the eluates were separated on a 12.5 % SDS-PAGE and proteins were visu-
alized by western blotting.
Transient Knockdown of TRN-SR in Cell Culture
The day prior to transient transfection, 50,000 HeLaP4 cells were seeded per
well in a 24-well plate for quantitative polymerase chain reaction (qPCR)
analysis. For HIV-1 infection, 200,000 cells were seeded per well in a 6-
well plate, and attachment to the plate was allowed overnight. For transient
knockdown in macrophages, 200,000 macrophages in one well of a 24-well
plate were used. Cells were transfected with 20 nM (HeLaP4) or 200 nM
(macrophages) siRNA following the guidelines of the siFECTamin protocol
(ICVEC, UK). The target sequences of the synthetic siRNA duplexes are
shown in Figure 1. Synthetic siRNAs were designed as follows: siTRNSR_1,
targeting nucleotides 352–371, 50-GGAGCGCGCCUCUUUUUGGdTdT-30
(QIAGEN, Netherlands); siTRNSR_2, targeting nucleotides 605–624, 50-UCG
GCGCACAGAAAUUAUAdTdT-30 (QIAGEN, Netherlands); siTRNSR_2MM,
targeting the same nucleotides, harboring four mutations (underlined),
50-UCGGCGCAGUCUAAUUAUAdTdT-30; siCD4, described previously, 50-
AAGATCAAGAGACTCCTCAGTdTdT-30 [46]; and siGFP (siRNA libraries,
Eurogentec, Belgium). For PIC nuclear-import assays, siRNA labeled with
30 Alexa Fluor 546 were used. In parallel, a transfection without siRNA
duplex was performed as a control and referred to as siMOCK-transfected.
HIV-1 Infection and Analysis of Transiently and Stably Transfected
HeLaP4 and Macrophages
Three days after transient transfection, HeLaP4 cells were detached from
the 6-well plates. Subsequently, 150,000 cells were brought into each well
of a 24-well plate for 4 hr at 37C. Of the stable cell lines, 150,000 cells
were seeded into each well of a 24-well plate and incubated for 4 hr at
37C. After attachment, cells were infected with HIV-1. Infections were per-
formed with three amounts of virus as determined by p24 measurement
(HIV-1 p24 ELISA kit, Perkin Elmer): 0.43 3 104, 1.1 3 104, and 2.2 3 104
pg p24 in a total volume of 250 ml. Each experiment was run in triplicate. After
3 hr of infection, the supernatant was removed and cells were washed three
times with PBS prior to addition of 0.5 ml DMEM-complete. At 24 and 72 hr
after infection of transient transfected cells, a single well was analyzed for b-
galactosidase activity (chemiluminescent b-Gal Reporter Gene Assay,
Roche Applied Science, Belgium). For the measurement of b-galactosidase
activity, care was taken to measure reporter activity in adherent and de-
tached cells. b-galactosidase activity was measured following the protocol
supplied by the manufacturer. Chemiluminescence was measured with the
Glomax (Promega, Belgium). The protein concentration of each sample was
determined (BCA Protein Assay Kit, Perbio), and read-outs were normalized
to 1 mg/ml total protein. At each time point analyzed, the persistence of
knockdown was demonstrated by quantitative PCR or western-blot analy-
sis. For the stable cell lines, aliquots of the supernatant were analyzed by
p24 measurements 48 hr and 72 hr after infection (HIV-1 p24 ELISA kit,Perkin Elmer). Infections of macrophages were performed with 1.6 3 106
pg p24 in 500 ml RPMI-complete. After overnight infection, the medium
was replenished. HIV-1 replication was monitored by p24 measurements
72, 144, and 192 hr after infection.
In Vivo PIC Nuclear-Import Assay
The HIV-IN-eGFP virus was obtained by transincorporation. In brief, 33 106
293T cells were transfected by calcium phosphate with 6 mg of pVpr-IN-
EGFP (Vpr and IN cloned into the pEGFP-N1 vector, Clontech Laboratories),
6 mg of pD64E (pNL4-3 clone containing the IN D64E inactivating mutation
obtained from the AIDS Reference and Reagent Program), and 1 mg of
pVSV-G. Supernatants were collected after 48 hr, filtered through a 0.45 mm
pore-size filter, and then concentrated by ultracentrifugation. Viral inocula
equivalent to 3 mg of HIV-1-p24 were used to infect 40,000 cells. Two hours
after infection, cells were incubated with trypsin (1 min) and fixed with 2%
paraformaldehyde. Three-dimensional stacks of fixed cells were acquired
with the TCS SL laser-scanning confocal microscope (Leica Microsystems)
equipped with galvanometric stage and a 63 3/1.4 NA HCX PL APO oil-
immersion objective. Z step size was 0.3 mm. Ar and HeNe laser lines
were used for EGFP (l = 488 nm), Alexa-568 (l = 514 nm), and Alexa-680
(l = 633 nm) excitation. Fluorescence emission was collected in the ranges
495–511, 556–640, and 644–795 nm for EGFP, Alexa-568, and Alexa-680,
respectively. For the two- and three-color analysis, a sequential image ac-
quisition was used to reduce crosstalk between different signals below
5%. Multichannel images were contrast stretched (linearly) and assembled
in ImageJ (NIH).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and
two figures and can be found with this article online at http://www.
current-biology.com/cgi/content/full/18/16/1192/DC1/.
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